Leal, Jenine
O’Grady, Heidi M.
Armstrong, Logan
Dixit, Devika
Khawaja, Zoha
Snedeker, Kate
Ellison, Jennifer
Erebor, Joyce
Jamieson, Peter
Weiss, Amanda
Salcedo, Daniel
Roberts, Kimberley
Wiens, Karen
Croxen, Matthew A.
Berenger, Byron M.
Pabbaraju, Kanti
Lin, Yi-Chan
Evans, David
Conly, John M.
Funding for this research was provided by:
Canadian COVID-19 Genomics Network
University of Calgary Infectious Diseases Research and Innovation Fund
Article History
Received: 5 October 2022
Accepted: 10 February 2023
First Online: 22 March 2023
Declarations
:
: The outbreak investigations were conducted in the setting of a formal Epidemiologic Investigation under Public Health in the Province of Alberta. The ARECCI (A Project Ethics Community Consensus Initiative) assessment scored this project as fitting with a quality improvement project for which Institutional Review Board approval was not required. The case control component and collection and culturing of patients was approved by the University of Calgary’s Conjoint Health Research Ethics Board (CHREB ID: REB21-0666 and REB20-0444, respectively). The ORION framework for reporting an outbreak or intervention study of a nosocomial organism was followed in this report.
: Not applicable.
: All authors will have filled out an ICMJE Disclosure form. JL reports Program funds from the Centre of Health Informatics at the University of Calgary used to provide in-Kind analytical support for her COVID-19 research, not related to this manuscript and funds paid to the University of Calgary to support professional development, specifically IPAC Canada 2022 Virtual conference fees were reimbursed by the Public Health Agency of Canada’s Canadian Nosocomial Infection Surveillance Program. All other authors do not have relevant conflicts of interest to declare related to any aspect of the submitted manuscript. All authors have reviewed the version of the manuscript which has been submitted.